CD274 and metastatic neoplasm: Only the gMDSC of HF-MOL(+)/α-PD-L1 treatment group decreased significantly, indicating that MOL(+)/α-PD-L1 could systematically consume gMDSC, and prevent abnormal splenic enlargement, which is a typical symptom of high metastatic tumor mice (Figure 21B).